Merit’s Margin Growth, Consistency Support 33% Stock Gain In 2002
This article was originally published in The Gray Sheet
Executive Summary
Merit Medical Systems enters 2003 with a core cardiovascular disposables franchise well positioned to take advantage of the advent of drug-eluting stents
You may also be interested in...
GPO Sole-Source Contract Reassessments Sought In Wake Of Senate Hearing
Masimo will re-submit its Signal Extraction Technology (SET) pulse oximetry device to Premier's "breakthrough technology" program in a bid to have the GPO re-evaluate its sole-source contract with Tyco
UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and reports progress on initiatives aimed at improving technology adoption. A schedule of ambitious future timelines has also been published.
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.